Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On
Name Title 2020 Bonus Dr. Leen Kawas President and Chief Executive Officer$ 357,000 Ms. Glenna Mileson Chief Financial Officer$ 215,600 Dr. Hans Moebius Chief Medical Officer$ 190,120 Dr. Mark Litton Chief Operating Officer$ 172,000 Dr. Kevin Church Vice President of Discovery$ 57,500
Item 7.01 Regulation FD Disclosure.
Commencing on or after
The information in Item 7.01 of this Current Report on Form 8-K, including the slides to be used in such one-on-one meetings attached as Exhibit 99.1 hereto, are being furnished and not filed pursuant to Item 7.01 of Form 8-K. Such information shall not be deemed to be "filed" for purposes of Section 18 of the Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference into any of the Company's filings under the Securities Act of 1933, as amended, or the Exchange Act whether made before or after the date hereof and regardless of any general incorporation language in such filings, except to the extent expressly set forth by specific reference in such a filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits. Exhibit No. Description 99.1Athira Pharma, Inc. Presentation Slides 2
--------------------------------------------------------------------------------
© Edgar Online, source